Treatment of Advanced Non-Small Cell Luna Cancer in 2018

被引：88
作者：
Doroshow, Deborah B. [1 ]
Herbst, Roy S. [1 ]
机构：
[1] Yale Canc Ctr, 333 Cedar St,POB 208028, New Haven, CT 06520 USA
来源：
JAMA ONCOLOGY | 2018年 / 4卷 / 04期
关键词：
PHASE-III; PEMBROLIZUMAB; CHEMOTHERAPY; OSIMERTINIB; CARBOPLATIN;
D O I：
10.1001/jamaoncol.2017.5190
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：569 / 570
页数：2
相关论文
共 50 条
  • [41] Advances in the Treatment of Non-Small Cell Lung Cancer
    Horn, Leora
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (5.5): : 764 - 767
  • [42] Impacts of Treatment Lines and Initiation Timing of Erlotinib for Advanced Non-small Cell Lung Cancer
    Aoki, Takuya
    Igawa, Satoshi
    Furuya, Naoki
    Katagiri, Masato
    Hisata, Junichirou
    Tajiri, Sakurako
    Hayama, Naoki
    Mineshita, Masamichi
    Urano, Tetsuya
    Miyazawa, Teruomi
    Masuda, Noriyuki
    Abe, Tadashi
    ANTICANCER RESEARCH, 2012, 32 (02) : 601 - 608
  • [43] What Is the Standard First-Line Treatment for Advanced Non-Small Cell Lung Cancer?
    Ricciuti, Biagio
    Awad, Mark M.
    CANCER JOURNAL, 2020, 26 (06) : 485 - 495
  • [44] Controversies around the use of monoclonal antibodies in the treatment of advanced non-small cell lung cancer
    Dediu, M.
    Ion, O.
    Ion, R.
    Gal, C.
    Median, D.
    Gongu, M.
    JOURNAL OF BUON, 2009, 14 : S159 - S164
  • [45] The role of combination chemo-immunotherapy in advanced non-small cell lung cancer
    Rocco, Danilo
    Della Gravara, Luigi
    Battiloro, Ciro
    Gridelli, Cesare
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (07) : 561 - 568
  • [46] Individualized Treatment for Advanced Non-Small Cell Lung Cancer: A Case Report and Literature Review
    Sun, Qianqian
    Li, Weiqing
    Liu, Taorui
    Guo, Huiqin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Medical treatment of advanced non-small cell lung cancer in elderly patients: A review of the role of chemotherapy and targeted agents
    Meoni, Giulia
    Cecere, Fabiana Letizia
    Lucherini, Elisa
    Di Costanzo, Francesco
    JOURNAL OF GERIATRIC ONCOLOGY, 2013, 4 (03) : 282 - 290
  • [48] Immunotherapy alone or chemo-immunotherapy as front-line treatment for advanced non-small cell lung cancer
    Shafique, Michael
    Tanvetyanon, Tawee
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (03) : 225 - 232
  • [49] Current treatment paradigms for locally advanced non-small cell lung cancer
    Rigas, James R.
    Kelly, Karen
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (06) : S77 - S85
  • [50] Treatment patterns and cost-effectiveness of first line treatment of advanced non-squamous non-small cell lung cancer in Medicare patients
    Gilden, Daniel M.
    Kubisiak, Joanna M.
    Pohl, Gerhardt M.
    Ball, Daniel E.
    Gilden, David E.
    John, William J.
    Wetmore, Stewart
    Winfree, Katherine B.
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (02) : 151 - 161
12345